A 2.7-kb portion of the 5' flanking region of the murine glycoprotein alpha(IIB) gene is transcriptionally active in primitive hematopoietic progenitor cells

被引:45
作者
Tropel, P
Roullot, V
Vernet, M
Poujol, C
Pointu, H
Nurden, P
Marguerie, G
TronikLeRoux, D
机构
[1] CEA, DEPT BIOL MOL & STRUCT, LAB TRANSGENESE & DIFFERENCIAT CELLULAIRE, F-38054 GRENOBLE 9, FRANCE
[2] HOP CARDIOL, CNRS, UMR 5533, LAB HEMOBIOL, PESSAC, FRANCE
关键词
D O I
10.1182/blood.V90.8.2995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The continuous generation of mature blood cells from primitive multipotent progenitor cells requires a highly complex series of cellular events that are still largely unknown. To examine the molecular events associated with the commitment of these hematopoietic progenitor cells to the megakaryocytic lineage, the alpha subunit of the platelet integrin alpha(IIb)beta(3) was used as marker. Despite an abundance of information regarding the role of this integrin in platelet adhesion and aggregation, the mechanisms that control the expression of the genes that code for these proteins are poorly understood and the earliest hematopoietic cell capable of expressing them has not been clearly identified. Thus, a strategy was developed to eradicate, using a conditional toxigene, all the hematopoietic cells capable of expressing the alpha(IIb) gene in mice. This was achieved by targeting the expression of the gene encoding the herpes simplex virus thymidine kinase (tk), specifically to these cell types, using a 2.7-kb fragment of the 5'-flanking region of the murine alpha(IIb) gene. Three transgenic lines having 1, 3, and 4 copies of the transgene, respectively were produced and analyzed. Administration of ganciclovir (GCV) to these mice induced a severe thrombocytopenia, which was due to the depletion of the entire megakaryocytic lineage, as shown by bone marrow (BM) culture and electron microscopy analysis. The time required to attain a severe thrombocytopenia was dependent on the level of the expression of the transgene and varied from 7 to 11 days. This condition was completely reversed when GCV treatment was discontinued. Progenitor cell assays showed that the alpha(IIb) promoter was active in primitive hematopoietic progenitor cells possessing myeloid, erythroid, and megakaryocytic potential and that the transcriptional activity of the promoter decreased progressively as differentiation proceeded towards the erythroid and myeloid lineages. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2995 / 3004
页数:10
相关论文
共 48 条
[41]   SINGLE-CELL ORIGIN OF MOUSE HEMATOPOIETIC COLONIES EXPRESSING MULTIPLE LINEAGES IN VARIABLE COMBINATIONS [J].
SUDA, T ;
SUDA, J ;
OGAWA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (21) :6689-6693
[42]   SUPPRESSION OF ERYTHRO-MEGAKARYOCYTOPOIESIS AND THE INDUCTION OF REVERSIBLE THROMBOCYTOPENIA IN MICE TRANSGENIC FOR THE THYMIDINE KINASE GENE TARGETED BY THE PLATELET GLYCOPROTEIN ALPHA-IIB PROMOTER [J].
TRONIKLEROUX, D ;
ROULLOT, V ;
SCHWEITZER, A ;
BERTHIER, R ;
MARGUERIE, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2141-2151
[43]   NEONATAL LETHALITY AND LYMPHOPENIA IN MICE WITH A HOMOZYGOUS DISRUPTION OF THE C-ABL PROTOONCOGENE [J].
TYBULEWICZ, VLJ ;
CRAWFORD, CE ;
JACKSON, PK ;
BRONSON, RT ;
MULLIGAN, RC .
CELL, 1991, 65 (07) :1153-1163
[44]  
UZAN G, 1991, J BIOL CHEM, V266, P8932
[45]   NUCLEOTIDE-SEQUENCE OF THE THYMIDINE KINASE GENE OF HERPES-SIMPLEX VIRUS TYPE-1 [J].
WAGNER, MJ ;
SHARP, JA ;
SUMMERS, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03) :1441-1445
[46]   C-MPL LIGAND IS A HUMORAL REGULATOR OF MEGAKARYOCYTOPOIESIS [J].
WENDLING, F ;
MARASKOVSKY, E ;
DEBILI, N ;
FLORINDO, C ;
TEEPE, M ;
TITEUX, M ;
METHIA, N ;
BRETONGORIUS, J ;
COSMAN, D ;
VAINCHENKER, W .
NATURE, 1994, 369 (6481) :571-574
[47]   GENERATION OF COMMITTED ERYTHROID BFU-E AND CFU-E PROGENITORS DOES NOT REQUIRE ERYTHROPOIETIN OR THE ERYTHROPOIETIN RECEPTOR [J].
WU, H ;
LIU, X ;
JAENISCH, R ;
LODISH, HF .
CELL, 1995, 83 (01) :59-67
[48]  
Young JC, 1996, BLOOD, V88, P1619